Dr. Daniel I. Silvershein, MD

  • New York, NY
  • Internist
NPI1932123213PAC ID0345131009
Medicare services, 2024
2,232
Medicare patients, 2024
280
Part D claims, 2024
3,940
Publications
1
MIPS score, 2024
93
Practice address
232 E 30th St, New York, NY 10016
Practice phone
Call (212) 447-1609
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Marcus Avenue Medical

New York, New York

See all 8 affiliations

Find Dr. Silvershein's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Daniel I. Silvershein is an internist in New York, New York

Dr. Silvershein practices at Marcus Avenue Medical in New York, New York.

Dr. Silvershein's NPI, 1932123213, was assigned on July 27, 2006. Dr. Silvershein graduated from Boston University School Of Medicine in 1993. Dr. Silvershein holds New York license 198821.

NPI and contact details
Medicare PAC ID
0345131009
NPI enumeration date
July 27, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(212) 447-1609
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
59
Medical school graduation
1993

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Daniel I. Silvershein practices at Marcus Avenue Medical in New York, New York

Dr. Silvershein's primary practice is Marcus Avenue Medical, at 232 E 30th St, New York, NY 10016 in New York County. The practice phone is (212) 447-1609.

  • Marcus Avenue Medical
    232 E 30th St, New York, NY 10016 · New York CountyPhone(212) 447-1609

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Daniel I. Silvershein is affiliated with 7 sites of care and 1 medical group

Dr. Silvershein's primary practice is Marcus Avenue Medical in New York, New York. Dr. Silvershein is also affiliated with Tisch Hospital. The medical group on file is Marcus Avenue Medical PC. Dmand AI also links Dr. Silvershein to 1 more hospital, 3 home health agencies and 1 group practice or clinic, each named with a free account.

See all 8 affiliations for Dr. Silvershein

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Daniel I. Silvershein's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Silvershein practices, 6 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Marcus Avenue MedicalAvailable with a free account
+6 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Silvershein practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Daniel I. Silvershein is one of 9,643 internists in New York

Internal medicine is Dr. Silvershein's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Silvershein is licensed in New York.

Specialties and state licenses

  • Internal medicine, New YorkPrimaryLicense 198821 · taxonomy 207R00000X

Internists near Dr. Silvershein

Counts of internists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Daniel I. Silvershein billed Medicare for 2,232 services in 2024

CMS data shows 2,232 Medicare services from Dr. Silvershein across 19 procedure codes in 2024, for 280 Medicare patients. Medicare paid $121,312 for them. Every service was in an office.

Medicare services, 20242,232
Medicare patients280
Paid by Medicare$121,312
Procedure codes19

Dr. Silvershein's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 6682024: 7187%
Other services
2023: 3322024: 705112%
Tests and treatments
2023: 3792024: 3624%
Surgery
2023: 3152024: 3398%
Drugs given in the office
2023: 1392024: 10822%

Dr. Silvershein compared with the New York median for internists, 2024

  • Dr. Silvershein
  • New York median
Medicare services
2,232vs 4265.2 times
Medicare patients
280vs 15877% above
Part D claims
3,202vs 6225.1 times

Medians across 9,428 internists in New York with Dmand AI profiles that report each measure.

Dr. Silvershein's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Silvershein

Need commercial claims for Dr. Silvershein?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Silvershein and other internists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Daniel I. Silvershein treated 280 Medicare patients in 2024, average age 76

CMS counts 280 Medicare patients who saw Dr. Silvershein in 2024. The largest group is 75 to 84, with 133 patients. 75% of them have high cholesterol, and 61% have high blood pressure. 4% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Silvershein's median patient age at 56, with 38% women.

Medicare patients, 2024280
Average age76
Average risk score0.98
Also on Medicaid4%

Dr. Silvershein's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Silvershein's Medicare patients by sex, 2024

  • Women14251%
  • Men13849%

Chronic conditions among Dr. Silvershein's Medicare patients, 2024

  1. High cholesterol75%
  2. High blood pressure61%
  3. Arthritis50%
  4. Ischemic heart disease31%
  5. Osteoporosis23%
  6. Anxiety19%
  7. Mood disorders17%
  8. Cancer16%

Share of Medicare patients with each condition. A patient can have several.

Dr. Silvershein's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 56

Patient panel by sex, all payers

  • Women38%
  • Men57%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Daniel I. Silvershein wrote 3,940 Medicare Part D claims in 2024

In 2024, Dr. Silvershein wrote 3,940 Medicare Part D claims for 361 patients. 84% of them were for generic drugs. CMS names the drug for 3,202 of them, across 101 drugs with 11 or more claims each, at $395,752 in total drug cost. In 2023, CMS named 2,934 claims across 92 drugs.

Part D claims, 20243,940
Drugs named by CMS101
Total drug cost$395,752
Part D patients361

Dr. Silvershein's Part D claims by kind of drug, 2024

  • Generic3,305 claims84%
  • Brand-name618 claims16%
  • Other17 claims0%

Dr. Silvershein's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Silvershein's Part D claims, 2024

  • Opioids1%40 of 3,940 claims
  • Antibiotics4%149 of 3,940 claims
  • Antipsychotics, patients 65 and over1%31 of 3,940 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 2,9342024: 3,2029%

Drugs named by CMS: 101 in 2024, 92 in 2023.

See all prescribing by Dr. Silvershein

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Daniel I. Silvershein scored 93 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Silvershein for performance year 2024, reported through an alternative payment model (APM). Dr. Silvershein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Silvershein as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Silvershein's MIPS scores, performance year 2024

  • 93of 100Final score
  • 79.8of 100Quality
  • 89of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find internists like Dr. Silvershein by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Daniel I. Silvershein has 1 publication on record

Dmand AI links 1 paper to Dr. Silvershein in 2015. Dr. Silvershein's most frequent co-author is Philip Felix Saltiel, MD.

Papers1

Dr. Silvershein's most frequent co-authors

Recent publications by Dr. Silvershein

See all 1 publications and co-authors

See who Dr. Silvershein researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Silvershein works with, so you can find a warm path to the right internists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Daniel I. Silvershein received $22,389 in industry payments from 2016 to 2024

CMS Open Payments shows 432 general payments to Dr. Silvershein from 42 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 35% of the total. Endo Pharmaceuticals Inc. paid the most, $14,666.

General payments to Dr. Silvershein by program year, 2016 to 2024

General payments to Dr. Silvershein by kind, 2016 to 2024

$22.4Kin total
  • Food and beverage$7,87735%
  • Speaker and faculty fees$6,38028%
  • Consulting fees$4,62521%
  • Travel and lodging$3,42515%
  • Education$820%

Companies that paid Dr. Silvershein the most, 2016 to 2024

Share is of all general payments to this clinician.

See all payments to Dr. Silvershein

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Daniel I. Silvershein graduated from Boston University School Of Medicine

Dr. Silvershein graduated from Boston University School Of Medicine in 1993.

  1. Medical schoolBoston University School Of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Daniel I. Silvershein's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Daniel I. Silvershein

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Daniel I. Silvershein's NPI number?

Dr. Daniel I. Silvershein's NPI number is 1932123213. It was assigned on July 27, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Daniel I. Silvershein?

Dr. Daniel I. Silvershein is an internist in New York, New York. The primary specialty in the NPI Registry is Internal Medicine Physician (taxonomy code 207R00000X).

Where does Dr. Daniel I. Silvershein practice?

Dr. Silvershein practices at 232 E 30th St, New York, NY 10016. Dr. Silvershein's primary practice is Marcus Avenue Medical in New York, New York. Dmand AI also links Dr. Silvershein to 1 hospital, 3 home health agencies and 1 group practice or clinic.

What is Dr. Daniel I. Silvershein's office phone number?

The practice phone on file for Dr. Silvershein is (212) 447-1609.

What is Dr. Daniel I. Silvershein's medical license number?

Dr. Silvershein holds New York license 198821.

Which hospitals is Dr. Daniel I. Silvershein affiliated with?

Dr. Silvershein is affiliated with Tisch Hospital. Dmand AI links Dr. Silvershein to 1 more hospital.

What medical group is Dr. Daniel I. Silvershein part of?

Dr. Silvershein is linked to Marcus Avenue Medical PC.

Does Dr. Daniel I. Silvershein accept Medicare?

Yes. CMS data shows Dr. Silvershein billed Medicare for 2,232 services in 2024, and Dr. Silvershein accepts Medicare assignment.

Does Dr. Daniel I. Silvershein offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Silvershein as offering telehealth services.

What is Dr. Daniel I. Silvershein's MIPS score?

Dr. Silvershein's MIPS final score for performance year 2024 is 93 out of 100, reported through an alternative payment model (APM).

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Daniel I. Silvershein see?

CMS counts 280 Medicare patients who saw Dr. Silvershein in 2024, with an average age of 76.

What services does Dr. Daniel I. Silvershein bill to Medicare?

In 2024, Dr. Silvershein's most billed Medicare services were office visit, established patient (99214), medicare service (G2211) and surgery: heart and blood vessels (36415).

Where did Dr. Daniel I. Silvershein go to medical school?

Dr. Silvershein graduated from Boston University School Of Medicine in 1993.

What drugs does Dr. Daniel I. Silvershein prescribe most?

In 2024 Medicare Part D data, Dr. Silvershein's most prescribed drugs by claims were Atorvastatin Calcium, Rosuvastatin Calcium and Levothyroxine Sodium.

Has Dr. Daniel I. Silvershein received payments from drug or device companies?

CMS Open Payments shows $22,389 in general payments to Dr. Silvershein from 42 companies from 2016 to 2024. The largest total came from Endo Pharmaceuticals Inc.

How long has Dr. Daniel I. Silvershein been practicing?

Dr. Silvershein graduated from medical school in 1993, 33 years ago.

Does Dr. Daniel I. Silvershein do research?

Dmand AI links 1 publication to Dr. Silvershein.

Who does Dr. Daniel I. Silvershein publish with?

Dr. Silvershein's most frequent co-authors are Philip Felix Saltiel, MD (1 shared paper).

Selling to internal medicine practices?

See internists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)